A woman who has lost more than three stone while taking Mounjaro has revealed how using the GLP-1 medication has 'ruined' her.

Get all the latest updates on Q1 results today, corporate announcements, dividend updates, board approvals, and guidance.

According to Research by SNS Insider, The U.S. GLP-1 Receptor Agonist Market to Reach USD 113.13 Billion by 2032, Driven by Rising Prevalence of Type 2 Diabetes and Demand for Obesity-Related ...

There is a growing trend of restaurants creating special menus of bite-sized entrées that cater to people on GLP-1 ...